ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
14 announcements with these filters
Zota Health Care responded to a proxy advisory firm's negative recommendations on upcoming AGM resolutions, defending proposed director remuneration and related party transactions with its subsidiary.
Zota Health Care Limited announced the cessation of Mrs. Varshabahen Gaurang Mehta as an Independent Director effective September 09, 2026, upon the completion of her tenure.
Zota Health Care Limited appointed Mr. Mahaveer Dhariwal as a Non-Executive Independent Director, effective September 3, 2026. The board approved this leadership appointment.
Zota Health Care has fixed September 21, 2026, as the record date for its upcoming Annual General Meeting and final dividend payment.
Zota Health Care Limited's board approved the Notice of the 26th AGM and set the record date for the final dividend. They also appointed a new Independent Director.
Zota reported 67.6% YoY revenue growth in Q1 FY27, driven by Davaindia network expansion. Management expects EBITDA positivity to resume from Q2 and cash breakeven by Q1 FY28.
Zota Health Care's Q1FY27 presentation highlights its massive Davaindia retail generic pharmacy expansion, now reaching 2,825 stores and driving 83% of company revenue.
Zota Health Care Ltd submitted its statement regarding QIP proceeds utilization. The company confirmed no deviation in fund usage for the quarter ended June 30, 2026.
Zota Health Care reported Q1FY27 consolidated revenue of ₹173.60 Crore, up 67.59% YoY. It also added 264 new stores, expanding its network to 2,825 outlets.
Zota Healthcare Ltd reported revenue from operations of ₹173.6 Cr (+67.6% YoY) and a net loss of ₹43.9 Cr for Q1 FY27.
Zota Health Care Limited will hold a board meeting on August 13, 2026, to consider and approve its quarterly unaudited financial results.
Zota Health Care issued a corrigendum to its Consolidated Cash Flow Statement for the year ended March 31, 2026, to rectify typographical errors.
Zota Health Care converted a Rs. 119.52 Crore unsecured loan into equity of its subsidiary Davaindia Health Mart. This debt-to-equity swap improves the group's consolidated net worth.
Zota Health Care acquired 2,35,512 shares in its subsidiary, Davaindia Health Mart, for Rs. 119.52 Crore. The transaction involved converting outstanding unsecured loans into equity.